Partnerships and alliances are becoming the most favoured method of operation for pharmaceutical companies looking to expand their geographic footprint and boost their capabilities and products basket. The summit will focus on areas of concern and challenges that need to be addressed at the stage of execution by Indian and foreign pharma companies as they continue to expand operations through alliances and partnerships in domestic market. The summit will also attempt to enable the Pharma Industry to crystallize the path ahead for its players in the domestic arena and identify sustainable business model for maximising growth.
• Provide a platform to discuss the changing business models in the industry
• Gain an understanding of the growing partnerships and alliances in the region
• Identify newer ways of managing cost pressures and bringing efficiencies across the pharma value chain
• Identify funding options for growth
• Outline newer trends like; health Insurance, Medical devices, Biologics, which are impacting growth of the industry and how pharma companies can devise suitable strategies to maximize the potential and catapult to the next level
• Evolving business models - To understand the growing need of alliances and partnerships and benefits realized.
To discuss strategies and challenges ahead
• Bringing Cost efficiencies - Identifying newer ways of managing cost pressures and bringing efficiencies across
the pharma value chain
• Newer growth trends - Understand how Health Insurance, Medical devices, Biologics, are impacting growth
of the industry
• Road Ahead - Given the changing dynamics of the industry and challenges ahead what are the imperatives for growth and how pharma companies can devise suitable strategies to maximize the potential and catapult to the next level
"India Pharma Inc.- Is Alliance & Partnership the Way Forward?"
"India Pharma Inc.- Newer Trends Driving the Growth"
"India Pharma Inc.- Managing Cost Pressures"
"Enhancing Value through Alliances and Partnerships"
Escalating healthcare cost
Generic competition eroding market share
Sharing risk to dilute pressure
Government-mandated price cuts
Product portfolio expansion
Geographical expansion
Declining R&D productivity
Cost savings from synergies
Pressures to maintain growth
Patent cliff
•
Identifying the evolving business models of pharma industry
•
Understanding the value potential of alliances and partnerships
•
Identifying critical success factors for alliances & partnerships
•
Identifying new ways of managing cost
pressures and bringing efficiencies
across the value chain
•
Identifying the impact of newer trends
– Health Insurance, Medical devices,
Biologics on the growth of the industry
•
Identify available funding options for
growing to the next level
•
Identifying key challenges and strategies
for the next level of growth